S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine

标题
S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine
作者
关键词
Pancreatic ductal adenocarcinoma, S100A16, Epithelial-mesenchymal transition, TWIST1, Gemcitabine
出版物
BIOCHEMICAL PHARMACOLOGY
Volume -, Issue -, Pages 114396
出版商
Elsevier BV
发表日期
2020-12-25
DOI
10.1016/j.bcp.2020.114396

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started